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Ras is a small GTP-binding protein in the signal transduction machinery.  In 
most cell types, activation of Ras by growth factors is essential for normal 
cell proliferation.  A mutation in the Ras gene can lead to a constitutive 
active (or oncogenic) state of Ras regardless of the upstream stimuli 
present.  In fact, about thirty percent of human cancer is associated with a 
mutation in the Ras gene.  When we generated transgenic mice over-expressing 
oncogenic Ras mutant in the ocular lens, we observed hyperplasia of the lens 
epithelial cells followed by vascularization in the lens fiber mass.  The 
purpose of this study is to examine the abnormal development of the vascular 
system in the Ras transgenic lens, and foremost to analyze the molecular 
mechanisms which induce these abnormalities.  Histological analysis was 
performed in three different transgenic lines to determine the onset of the 
lens vascularization.  We found that the lens capsule, which is the basement 
membrane of the lens cells, was disrupted in the transgenic mice.  
Subsequently, the hyaloid vascular cells surrounding the lens began to invade 
into the transgenic lens at embryonic day 13 to 15.  Furthermore, the 
transgenic mice from the highest expressing lines develop the blood vessel in 
the lens at the earliest stage and in the most severe state, suggesting that 
the defect has a direct correlation with the oncogenic Ras activity.  Semi-
quantitative RT-PCR was used to examine gene expression levels in the wild 
type and Ras transgenic lenses.  Results showed that oncogenic Ras induces 
upregulation of the genes which are responsible for angiogenesis, such as 
vascular endothelial growth factor (VEGF), hypoxia-inducible factor1(HIF1), 
and erythropoietin (EPO).  Additionally, the genes involved in basement 
membrane remodeling, including matrix metalloproteinase 2, 9, and 14 (MMP-2, 
9, 14), were also upregulated in the transgenic lens.  We conclude that the 
Ras transgenic mice can be used as an alternative in vivo model for the study 
of angiogenesis and vascularization during cancer development. 
